{
  "trial_id": "NCT00783393",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "histologically confirmed anaplastic astrocytoma on the tentorium at first relapse",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "unequivocal evidence of tumor recurrence or aggravation by MRI scan after treatment for initial onset",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "anaplastic astrocytoma diagnosed histologically by the last pathological diagnostic tests (including initial diagnosis) prior to initial administration of temozolomide",
      "label": "met",
      "evidence": "pathologic diagnosis report"
    },
    {
      "criterion": "tissue samples available for Central Pathologic Reviewer",
      "label": "met",
      "evidence": "available"
    },
    {
      "criterion": "MRI scan performed within 14 days before initial temozolomide administration",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "assessable tumor site confirmed by MRI",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "Age >=18 years, either sex, inpatients or outpatients",
      "label": "met",
      "evidence": "patient's age and status"
    },
    {
      "criterion": "Use of medically approved contraception methods in fertile subjects",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Karnofsky performance status >=70",
      "label": "met",
      "evidence": "patient's condition"
    },
    {
      "criterion": "Adequate clinically laboratory values obtained within 14 days before initial temozolomide administration",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "tumor biopsy, regardless of tumor resection at initial diagnosis",
      "label": "met",
      "evidence": "biopsy report"
    },
    {
      "criterion": "prior radiation therapy",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of treatment with dacarbazine",
      "label": "triggers",
      "evidence": "history of treatment"
    },
    {
      "criterion": "Subjects who received chemotherapy within 6 weeks before initial temozolomide administration",
      "label": "triggers",
      "evidence": "patient's history of chemotherapy"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and has undergone radiation therapy. However, they have also received chemotherapy within the past 6 weeks, which is a contraindication for this trial.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00783393",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}